FDA Promises Interchangeability For Alvotech’s 100mg/ml Humira Rival – If It Passes Inspection

April 2023 Approval For AVT02 Adalimumab Biosimilar Hinges On Facility Nod

 
• By Dave Wallace
  
13 April Calendar
The FDA goal date for AVT02 is 13 April 2023 • Source: Shutterstock

More from Biosimilars

More from Products